Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
Baylor College of Medicine
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Centre Oscar Lambret
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Children's Oncology Group
Emory University
M.D. Anderson Cancer Center
USWM, LLC (dba US WorldMeds)
Children's Oncology Group
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
Takara Bio Inc.
Children's Oncology Group
Children's Oncology Group
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Baylor College of Medicine
Children's Oncology Group
Baylor College of Medicine
Milton S. Hershey Medical Center
Masonic Cancer Center, University of Minnesota
Stichting Hemato-Oncologie voor Volwassenen Nederland
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Institut Bergonié
Eli Lilly and Company
University Health Network, Toronto
University Health Network, Toronto
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Sun Yat-sen University
University of Arizona
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Hadassah Medical Organization
Valo Therapeutics Oy
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
University of Pittsburgh
Masonic Cancer Center, University of Minnesota